UNVERIFIEDSingle Source
Stocks making the biggest moves premarket: Novo Nordisk, JPMorgan Chase, United Airlines & more
CNBC|4/14/2026
N
Novo
50 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
26
Activity (Last 30 Days)
1
1
1
1
1
1
2026-03-232026-04-14
Top Publishers
Reuters8 stories
CNBC5 stories
Google News4 stories
Financial Times3 stories
Euronews2 stories
Stories (Latest First)
UNVERIFIEDSingle Source
Weight-loss drugs and Mars bars: Novo Nordisk’s comeback bid
Financial Times|4/13/2026
UNVERIFIEDSingle Source
Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
Reuters|4/2/2026
UNVERIFIEDSingle Source
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US
Reuters|3/31/2026
UNVERIFIEDSingle Source
China’s weight-loss drug makers take on global giants as Novo Nordisk patent expires
South China Morning Post|3/26/2026
UNVERIFIEDSingle Source
Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
Reuters|3/23/2026
UNVERIFIEDSingle Source
Another weight-loss pill in the works, as Ozempic-maker Novo Nordisk strikes deal with Boston startup
The Boston Globe|2/25/2026
UNVERIFIEDSingle Source
Stocks making the biggest moves midday: IBM, AMD, Dillard's, Novo Nordisk, Keysight Technologies & more
CNBC|2/24/2026
UNVERIFIEDSingle Source
Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino's Pizza and more
CNBC|2/23/2026
UNVERIFIEDSingle Source
Novo Nordisk slump wipes out last Wegovy-era gains after trial setback
Reuters|2/23/2026
UNVERIFIEDSingle Source
Novo Nordisk shares drop after poor trial results for new obesity drug
Financial Times|2/23/2026
UNVERIFIEDSingle Source
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
Reuters|2/23/2026
UNVERIFIEDSingle Source
Stocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger and more
CNBC|2/9/2026
UNVERIFIEDSingle Source
US health company launches weight-loss pill that Novo Nordisk calls an 'untested knockoff'
Euronews|2/6/2026
UNVERIFIEDSingle Source
Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly
Reuters|2/5/2026
UNVERIFIEDSingle Source
Wegovy-maker Novo Nordisk warns of 'unprecedented' price pressure as shares tumble
Reuters|2/4/2026
UNVERIFIEDSingle Source
Novo Nordisk sees lower sales, profits as Wegovy faces growing competition - statnews.com
Stat News|2/3/2026
UNVERIFIEDSingle Source
Stocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and more
CNBC|2/3/2026
UNVERIFIEDSingle Source
Obesity market sales potential tightens as Novo and Lilly enter new era
Reuters|2/2/2026
UNVERIFIEDSingle Source
BMO Raises Novo Nordisk A/S (NVO) Price Target but Flags Prescription Pressures
Insider Monkey|1/31/2026
UNVERIFIEDSingle Source
Novo's Wegovy Pill Looks A Lot Like Zepbound — In One Week - Investor's Business Daily
Google News|1/16/2026
UNVERIFIEDSingle Source
Novo Nordisk wins 3,071 prescriptions for Wegovy pill (NVO:NYSE) - Seeking Alpha
Google News|1/16/2026
UNVERIFIEDSingle Source
Novo's Wegovy pill tracks 3,071 prescriptions in first days of launch - Reuters
Google News|1/16/2026
UNVERIFIEDSingle Source
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference - CNBC
Google News|1/14/2026